Hyloris Pharmaceuticals SAEURONEXT: HYL

Licenses European and Turkish Rights to Next-Generation Wilson’s Disease Candidate from ArborMed

· Issued by Hyloris Pharmaceuticals SA

On 6ix: 6ix.com/news/hyloris-pharmaceuticals-licenses-european-and-turkish-rights-to-next-generation-wilsons-disease-candidate-from-arbormed

30 Dec 2025 18:20 CET

Subscribe
Issuer

HYLORIS PHARMACEUTICALS SA

pressreleasehylorisarbormedlicense-european-rightswilson-diseasefinalen20251230.pdf

Source

HYLORIS

Provider

Euronext

Company Name

HYLORIS

ISIN

BE0974363955

Symbol

HYL

Market

Euronext

Hyloris Pharmaceuticals SA on 6ix

Story so far

Earlier from Hyloris Pharmaceuticals

Later from Hyloris Pharmaceuticals

All Hyloris Pharmaceuticals news releases